Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)

NCT ID: NCT03257436

Last Updated: 2022-01-03

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

586 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-01-05

Study Completion Date

2020-11-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prospective, multi-center, single arm, post approval study to be conducted in the United States.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Evaluate the effectiveness of Boston Scientific (BSC)'s LV MSP (Left Ventricular MultiSite Pacing) feature in the Resonate family of CRT-D devices and confirm safety in a post approval study when used in accordance with its approved labeling.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Left Ventricular Dysfunction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Single Arm

General population who receive a Boston Scientific Resonate family of CRT-D device in accordance with its labeled indication for use.

Group Type OTHER

CRT-D

Intervention Type DEVICE

Left Ventricular MultiSite Pacing

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CRT-D

Left Ventricular MultiSite Pacing

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Subjects who received de novo implantation of BSC's Resonate family of CRT-D devices with the LV MSP feature4 and BSC's ACUITYTM X4 LV Quadripolar leads. A Resonate family of CRT-D device upgrade from previous single or dual chamber pacemaker or ICD implantation is allowed.
2. Subjects must meet BSC labeled indication for CRT-D implantation.
3. Subjects must have a functional RA lead and RV lead implanted
4. Subjects who are willing and capable of providing informed consent
5. Subjects who are willing and capable of participating in all testing/visits associated with this clinical study at an approved clinical study center and at the intervals defined by this protocol
6. Subjects who are age 18 and above, or of legal age to give informed consent specific to state and national law

Exclusion Criteria

1. Subjects who received LV pacing prior to receiving the Resonate family of CRT-D system implantation.
2. Subjects who received the LV MSP therapy post CRT-D implantation but prior to enrollment
3. Subjects with documented history of permanent AF
4. Subjects with documented permanent complete AV block
5. Subjects who are expected to receive a heart transplant during the 12 months course of the study
6. Subjects with documented life expectancy of less than 12 months
7. Subjects who enrolled in any other concurrent study or registry, with the exception of mandatory national or governmental registry, without prior written approval from BSC
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Boston Scientific Corporation

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Saba Samir

Role: PRINCIPAL_INVESTIGATOR

University of Pittsburgh Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mobile Infirmary Medical Center

Mobile, Alabama, United States

Site Status

Phoenix Cardiovascular Group

Phoenix, Arizona, United States

Site Status

Cardiology Associates of NEA

Jonesboro, Arkansas, United States

Site Status

Foothill Cardiology Medical Group

Arcadia, California, United States

Site Status

Chula Vista Cardiac Center

Chula Vista, California, United States

Site Status

Kaiser Permanente Los Angeles Medical Center

Los Angeles, California, United States

Site Status

Desert Heart Rhythm Consultants

Palm Springs, California, United States

Site Status

Cardiology Associates Medical Group

Ventura, California, United States

Site Status

Yale University School of Medicine

New Haven, Connecticut, United States

Site Status

Delray Medical Center

Delray Beach, Florida, United States

Site Status

UF Health Jacksonville

Jacksonville, Florida, United States

Site Status

Florida Hospital Waterman

Lake Mary, Florida, United States

Site Status

Tallahassee Research Institute

Tallahassee, Florida, United States

Site Status

Augusta University

Augusta, Georgia, United States

Site Status

Alexian Brothers Hospital Network

Elk Grove Village, Illinois, United States

Site Status

Carle Foundation Hospital

Urbana, Illinois, United States

Site Status

Parkview Hospital Inc

Fort Wayne, Indiana, United States

Site Status

University of Kansas Medical Center

Kansas City, Kansas, United States

Site Status

Norton Heart Specialist

Louisville, Kentucky, United States

Site Status

Advanced Cardiovascular Specialists

Shreveport, Louisiana, United States

Site Status

MedStar Heart and Vascular Institute

Baltimore, Maryland, United States

Site Status

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States

Site Status

Ascension St. John Hospital & Medical Center

Detroit, Michigan, United States

Site Status

Genesys Regional Medical Center

Grand Blanc, Michigan, United States

Site Status

St. Mary's of Michigan Research Institute at Covenant Medical Ceter

Saginaw, Michigan, United States

Site Status

UMMC- Division of Cardiology

Jackson, Mississippi, United States

Site Status

St. Lukes Hospital

Kansas City, Missouri, United States

Site Status

Billings Clinic

Billings, Montana, United States

Site Status

Methodist Physicians Clinic Heart Consultants

Omaha, Nebraska, United States

Site Status

Deborah Heart and Lung Center

Browns Mills, New Jersey, United States

Site Status

Hackensack University Medical Canter

Hackensack, New Jersey, United States

Site Status

Montefiore Medical Center

The Bronx, New York, United States

Site Status

Durham VA medical Center

Durham, North Carolina, United States

Site Status

WakeMed

Raleigh, North Carolina, United States

Site Status

Trihealth- Good Samaritan & Bethesda North Hospitals

Cincinnati, Ohio, United States

Site Status

The Ohio State University Wexner Medical Center

Columbus, Ohio, United States

Site Status

St. Elizabeth Youngstown Hospital

Youngstown, Ohio, United States

Site Status

Salem Health

Salem, Oregon, United States

Site Status

Penn Presbyterian Medical Center

Philadelphia, Pennsylvania, United States

Site Status

UPMC Presbyterian

Pittsburgh, Pennsylvania, United States

Site Status

Pinnacle Health Cardiovascular Institute

Wormleysburg, Pennsylvania, United States

Site Status

Berk Cardiologists

Wyomissing, Pennsylvania, United States

Site Status

AnMed Health Clinical Research

Anderson, South Carolina, United States

Site Status

Rapid City Regional Health

Rapid City, South Dakota, United States

Site Status

Stern Cardiovascular Foundation

Germantown, Tennessee, United States

Site Status

Vanderbilt University Medical Center

Nashville, Tennessee, United States

Site Status

Heartplace, PA

Bedford, Texas, United States

Site Status

Brooke Army Medical Center

Fort Sam Houston, Texas, United States

Site Status

UT Health

Houston, Texas, United States

Site Status

University of Utah

Salt Lake City, Utah, United States

Site Status

University of Virginia

Charlottesville, Virginia, United States

Site Status

Carient Heart and Vascular

Manassas, Virginia, United States

Site Status

Sentara Norfolk General

Norfolk, Virginia, United States

Site Status

St. Mary's Medical Center

Huntington, West Virginia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

92050975

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.